EP 1343913 A2 20030917 - ANTISENSE MODULATION OF SRC-2 EXPRESSION
Title (en)
ANTISENSE MODULATION OF SRC-2 EXPRESSION
Title (de)
ANTISENSE-MODULATION DER SRC-2-EXPRESSION
Title (fr)
MODULATION ANTISENS DE L'EXPRESSION DE SRC-2
Publication
Application
Priority
- US 0144220 W 20011126
- US 72353000 A 20001127
Abstract (en)
[origin: WO0242423A2] Antisense compounds, compositions and methods are provided for modulating the expression of SRC-2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding SRC-2. Methods of using these compounds for modulation of SRC-2 expression and for treatment of diseases associated with expression of SRC-2 are provided.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 31/7088 (2006.01); A61K 48/00 (2006.01); A61P 43/00 (2006.01); C12N 15/113 (2010.01); A61K 38/00 (2006.01)
CPC (source: EP)
A61P 43/00 (2017.12); C12N 15/113 (2013.01); A61K 38/00 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/3341 (2013.01); C12N 2310/341 (2013.01); C12N 2310/346 (2013.01); Y02P 20/582 (2015.11)
C-Set (source: EP)
Citation (search report)
See references of WO 0242423A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0242423 A2 20020530; WO 0242423 A3 20030130; AU 3767802 A 20020603; EP 1343913 A2 20030917; JP 2004536558 A 20041209
DOCDB simple family (application)
US 0144220 W 20011126; AU 3767802 A 20011126; EP 01986485 A 20011126; JP 2002545129 A 20011126